Light Chain Bioscience at PEGS Europe 2026
Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website
Light Chain Bioscience brings 3 presentations to PEGS Europe 2026 in Lisbon. Its program centres on tumour-selective CD47 targeting for platinum-resistant ovarian cancer, in the track on engineering next-generation bispecific antibodies.
| Organization | PEGS Europe 2026 Attendance |
|---|---|
Light Chain Bioscience Plan-les-Ouates, Switzerland | |
NovImmune brand developing kappa-lambda bispecific antibodies, including tumour-selective CD47 programmes. | Chair Thu Nov 19 8:25am–8:30am Chair Thu Nov 19 10:44am–10:45am Talk Thu Nov 19 2:05pm–2:35pm |
Find decision makers at Light Chain Bioscience
Tell us what you sell and we’ll find the people at Light Chain Bioscience most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction